This is presumed to be why many reports on the effects of early diagnosis on inherited breast cancer have combined BRCA1 and BRCA2 mutation carriers together to provide sufficient enough cases to arrive at a significant conclusion. The gene discussed is BRCA2; the disease is breast cancer.